It marks the first time a patient intentionally controlled previously paralysed functions within the first two weeks of stimulation, researchers said.
The results offer evidence that a combination of this technology and rehabilitation may help patients with spinal cord injuries regain control over previously paralysed movements, such as steplike actions, balance control and standing.
"We're really excited, because our results went beyond our expectations," said Kendall Lee, director of Mayo Clinic's Neural Engineering Laboratory in the US.
He was diagnosed with a motor complete spinal cord injury, meaning he could not move or feel anything below the middle of his torso.
The study started with the patient going through 22 weeks of physical therapy. He had three training sessions a week to prepare his muscles for attempting tasks during spinal cord stimulation.
He was tested for changes regularly. Some results led researchers to characterise his injury further as discomplete, suggesting dormant connections across his injury may remain.
The electrode is connected to a computer-controlled device under the skin in the patient's abdomen. This device sends electrical current to the spinal cord, enabling the patient to create movement.
After a three-week recovery period from surgery, the patient resumed physical therapy with stimulation settings adjusted to enable movements.
In the first two weeks, he intentionally was able to control his muscles while lying on his side, resulting in leg movements.
He was also able to make steplike motions while lying on his side and standing with partial support as well as stand independently using his arms on support bars for balance.
"This has really set the tone for our post-surgical rehabilitation - trying to use that function the patient recovered to drive even more return of abilities," said Kristin Zhao, director of Mayo Clinic's Assistive and Restorative Technology Laboratory.
The data suggest that people with discomplete spinal cord injuries may be candidates for epidural stimulation therapy.
The research was published in the journal Mayo Clinic Proceedings.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
